FDA Drafts Guidance on Handling Deficient Animal Drug Submissions

Summary

The Food and Drug Administration (FDA) is seeking public comment on a draft guidance document outlining the FDA's policy for handling deficient submissions related to new animal drugs. The draft guidance, titled 'How the Center for Veterinary Medicine Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug,' aims to clarify the circumstances under which the FDA will discontinue review of such submissions.